Dominique Bonafoux
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dominique Bonafoux.
Bioorganic & Medicinal Chemistry Letters | 2011
Dominique Bonafoux; Ayome Abibi; Brian Bettencourt; Andrew Burchat; Anna M. Ericsson; Christopher M. Harris; Tegest Kebede; Michael J. Morytko; Michael J. McPherson; Grier A. Wallace; Xiaoyun Wu
The bioisosteric replacement of the indole core of CRTH2 antagonists using thienopyrroles was investigated, resulting in potent antagonists with good selectivity over DP1. Early ADME/PK assessment of this chemotype demonstrated bioavailability in mice.
Bioorganic & Medicinal Chemistry Letters | 2009
Dominique Bonafoux; Claudio Chuaqui; P. Ann Boriack-Sjodin; Chris Fitch; Gretchen Hankins; Serene Josiah; Cheryl Black; Gregg Hetu; Leona E. Ling; Wen-Cherng Lee
The 4-(5-fluoro-6-methyl-pyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-ylamine 3 is a potent and selective inhibitor of TGF-betaR1. Substitution of the amino group of 3 typically led to a slight decrease in the affinity for the receptor and in TGF-beta-inducted PAI-luciferase reporter activity. However, 2-acetamidoimidazoles were identified as attractive candidates for further optimization as a result of their significant activity combined to their superior pharmacokinetic profile.
Bioorganic & Medicinal Chemistry | 2010
Dominique Bonafoux; Sheri L. Bonar; Michael Clare; Ann M. Donnelly; Jeanette L. Glaenzer; Julia A. Guzova; He Huang; Nandidni N. Kishore; Francis Koszyk; Patrick J. Lennon; Adam Libby; Sumathy Mathialagan; David S. Oburn; Sharon Rouw; Cynthia D. Sommers; Catherine Tripp; Lori J. Vanella; Richard Weier; Serge G. Wolfson; Horng-Chih Huang
Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and in IL-1beta stimulated synovial fibroblasts. The 2-amino-5-chloropyridine-4-carboxamides were identified as the most potent inhibitors with improved cellular activity.
Bioorganic & Medicinal Chemistry Letters | 2005
Dominique Bonafoux; Sheri L. Bonar; Lori Christine; Michael Clare; Ann M. Donnelly; Julia A. Guzova; Nandini Kishore; Patrick J. Lennon; Adam Libby; Sumathy Mathialagan; William D. Mcghee; Sharon Rouw; Cindy Sommers; Michael B. Tollefson; Catherine Tripp; Richard Weier; Serge G. Wolfson; Yao Min
Archive | 2014
Dominique Bonafoux; Heather M. Davis; Kristine E. Frank; Michael M. Friedman; J. Martin Herold; Michael Z. Hoemann; Raymond Huntley; Augustine Osuma; George S. Sheppard; Gagandeep Somal; Jennifer Van Camp; Stacy Van Epps; Anil Vasudevan; Grier A. Wallace; Lu Wang; Zhi Wang; Noel S. Wilson; Xiangdong Xu
Archive | 2005
Dominique Bonafoux; Michael Clare; Theresa R. Fletcher; Bruce C. Hamper; Patrick J. Lennon; William D. Mcghee; David S. Oburn; Matthew T. Reding; Michael B. Tollefson; Serge G. Wolfson
Archive | 2004
Patrick J. Lennon; Dominique Bonafoux; Sergey Gregory Wolfson
Archive | 2015
Xiangdong Xu; Noel S. Wilson; Zhi Wang; Lu Wang; Grier A. Wallace; Anil Vasudevan; Stacy Van Epps; Jennifer Van Camp; Gagandeep Somal; George S. Sheppard; Augustine Osuma; Raymond Huntley; Michael Z. Hoemann; J. Martin Herold; Michael M. Friedman; Kristine E. Frank; Heather M. Davis; Dominique Bonafoux
Archive | 2014
Dawn M. George; Maria A. Argiriadi; Martine Barth; Dominique Bonafoux; Eric C. Breinlinger; Linlin Dai; Jeremy John Edmunds; Michael M. Friedman; Fabrice Guillier; Adrian D. Hobson; Dominique Potin; Didier Thomas; Jianfei Wang; Wentao Wu; Yang Zhang
Archive | 2006
Wen-Cherng Lee; Claudio Chuaqui; Lihong Sun; Michael Hoemann; Deqiang Niu; Dingxue Yan; Dominique Bonafoux; Mark Cornebise